Stockscreener 앱 받기
42.81
0.74%
-0.32
시간 외 거래:
42.79
-0.02
-0.05%
Qiagen Nv 주식(QGEN)의 최신 뉴스
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Activist Fivespan has a stake in Qiagen. Here are 3 levers to boost the company's growth and improve value - NBC4 Washington
Global Molecular Diagnostics Market to Expand at a CAGR of ~9% by 2032 Due to the Rising Demand for Precision Medicine | DelveInsight - GlobeNewswire Inc.
Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
RNA Editing Market Deep Research 2025-2032 | QIAGEN N.V., ProQR - openPR.com
QIAGEN Expands Its Digital PCR Portfolio With New Lentivirus Solutions to Strengthen Cell and Gene Therapy Quality Control - DutchNews.nl
Why Qiagen (QGEN) is a Top Value Stock for the Long-Term - Yahoo Finance
QIAGEN Announces Details for Completion of Synthetic Share Repurchase of up to Approximately $300 Million - ADVFN
QIAGEN NV : UBS reiterates its Neutral rating - marketscreener.com
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025 | QGEN Stock News - GuruFocus
QIAGEN Advances Cancer Genomic Profiling With New Products and Partnership Updates at AACR Annual Meeting 2025 - Yahoo Finance
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 33% Undervaluation? - Yahoo Finance
QIAGEN N.V. Prepares to Release 2024 Financial Reports - TipRanks
PTA-AFR: QIAGEN N.V.: Pre-announcement of a financial report according to articles 114117 WpHG - TradingView
QIAGEN Advances Cancer Genomic Profiling With New Products and P - GuruFocus
Baird Increases Price Target for Qiagen (QGEN) Ahead of Q1 Resul - GuruFocus
What Qiagen N.V.'s (NYSE:QGEN) P/S Is Not Telling You - simplywall.st
Fivespan Said to Build Stake in Life Sciences Group Qiagen - MSN
Qiagen's Future Under The Microscope After Stake Purchase - Finimize
Qiagen’s Voting Rights Announcement Involves Major Financial Entities - TipRanks
Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Fivespan Is Said to Build Stake in Life Sciences Group Qiagen - MSN
Activist investor Fivespan takes stake in QiagenBloomberg - MSN
Fivespan Partners Positions Itself in Qiagen (QGEN) Amid Activis - GuruFocus
Qiagen Holds Talks With Fivespan as Activist Investor Builds Stake - marketscreener.com
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation - 01net
QIAGEN's Lab Revolution: New Automation Systems Promise 3x Faster Sample Processing - Stock Titan
Qiagen (QGEN) Target Price Reduced Amid Negative Market Sentimen - GuruFocus
BofA Securities Cuts Price Target on Qiagen to $50 From $55, Maintains Buy Rating - MarketScreener
QIAGEN Announces Voting Rights Notification by AFM - TipRanks
Qiagen gains after guidance raise - MSN
Qiagen Announces Change in Total Voting Rights - TipRanks
PTA-NVR: QIAGEN N.V.: Total Voting Rights Announcement according to Article 41 of the WpHG - TradingView
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast - sharewise.com
QIAGEN Earnings Alert: Key Q1 2025 Results Coming May 7What to Watch - Stock Titan
Qiagen Q1 Preliminary Adjusted Earnings Beat Guidance; 2025 Outlook Lifted -- Shares Rise - MarketScreener
0.34%
0.46%
자본화:
|
볼륨(24시간):